Incyte Corporation

April J A Hafalia

Henry Yue

Mariah R Baughn

Ameena R Gandhi

Monique G Yao

Yan Lu

Anita Swarnakar

Craig H Ison

Preeti G Lal

Y Tom Tang

Neil Burford

Vicki S Elliott

Li Ding

Olga Bandman

Dyung Aina M Lu

Danniel B Nguyen

Bridget A Warren

Junming Yang

Narinder K Chawla

Rajagopal Gururajan

Brendan M Duggan

Yuming Xu

Bao M Tran

Sally Lee

Michael B Thornton

Kimberly J Gietzen

Madhusudan M Sanjanwala

Michael Thorton

Cynthia D Honchell

Ernestine A Lee

Catherine M Tribouley

Soo Yeun Lee

Jayalaxmi Ramkumar

Uyen K Tran

Ian J Forsythe

Pei Jin

Reena Khare

Thomas W Richardson

Joseph P Marquis

Shanya D Becha

Narinder K Walia

Chandra S Arvizu

Wen Luo

Kavitha Thangaveln

Joana X Li

Amy D Wilson

Stephanie Kareht

Kavitha Thangavelu

Farrah A Khan

Narinder K Chawla-Walia

Janice K Au-Young

Jennifer L Policky

Liam Kearney

Stephanie K Sapperstein

Vicki S Kaulback

Debopriya Das

Jennifer L Hillman

Phillip R Hawkins

Yalda Azimzai

Angelo M Delegeane

Roopa M Reddy

Xin Jiang

Gregory Marcus

John D Burrill

Kurt A Zingler

Preeti G Lai

Jennifer A Griffin

Stephen Todd

Deborah A Kallick

Mark L Borowsky

Roberto Hernandez

Vicki S Elliott Kaulback

Patricia M Lehr-Mason

Ann E Gorvad

Amy E Kable

David Chien

Alan A Jackson

Sean A Bulloch

The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.

Secreted proteins

Antibody to secreted polypeptide

Various embodiments of the invention provide human kinases and phosphatases (KPP) polypeptides and polynucleotides which identify and encode KPP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KPP.

Antibodies to human &#x3b2;-adrenergic receptor kinase

Human &#x3b2;-adrenergic receptor kinase polypeptide and methods

Various embodiments of the invention provide human kinases and phosphatases (KPP) and polynucleotides which identify and encode KPP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KPP.

Human &#x3b2;-adrenergic receptor kinase nucleic acid molecule

Various embodiments of the invention provide human receptors and membrane-associated proteins (REMAP) and Q polynucleotides which identify and encode REMAP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of REMAP.

CD40-related receptor that binds CD40L

The invention provides human lipid metabolism enzymes (LME) and polynucleotides which identify and encode LME. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of LME.

Human phospholipases

The invention provides human human kinases (PKIN) and polynucleotides which identify and encode PKIN. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PKIN.

Human cAMP-dependent protein kinase beta-catalytic subunit

The invention provides human kinases and phosphatases (KAP) and polnucleotides which identify and encode KAP. The invention also provides expresson vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KAP.

Human protein phosphatase 2C

The invention provides a human cysteine proteases and polynucleotides which encode those proteases. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists, as well as methods for diagnosing, treating, or preventing disorders associated with aberrant expression of cysteine proteases.

Proteases

Growing community of inventors

Daly City, CA, United States of America

April J A Hafalia